Pathogenetic profiling of COVID-19 and SARS-like viruses

Nain, Z, Rana, HK, Liò, P, Shariful Islam, Sheikh, Summers, MA and Moni, MA 2021, Pathogenetic profiling of COVID-19 and SARS-like viruses, Briefings in Bioinformatics, vol. 22, no. 2, pp. 1175-1196, doi: 10.1093/bib/bbaa173.

Attached Files
Name Description MIMEType Size Downloads

Title Pathogenetic profiling of COVID-19 and SARS-like viruses
Author(s) Nain, Z
Rana, HK
Liò, P
Shariful Islam, SheikhORCID iD for Shariful Islam, Sheikh orcid.org/0000-0001-7926-9368
Summers, MA
Moni, MA
Journal name Briefings in Bioinformatics
Volume number 22
Issue number 2
Start page 1175
End page 1196
Total pages 22
Publisher Oxford University Press
Place of publication Oxford, Eng.
Publication date 2021-03
ISSN 1467-5463
1477-4054
Keyword(s) 2019-nCoV
COVID-19
SARS-CoV-2
comorbidities
coronavirus
microarray
Summary The novel coronavirus (2019-nCoV) has recently emerged, causing COVID-19 outbreaks and significant societal/global disruption. Importantly, COVID-19 infection resembles SARS-like complications. However, the lack of knowledge about the underlying genetic mechanisms of COVID-19 warrants the development of prospective control measures. In this study, we employed whole-genome alignment and digital DNA-DNA hybridization analyses to assess genomic linkage between 2019-nCoV and other coronaviruses. To understand the pathogenetic behavior of 2019-nCoV, we compared gene expression datasets of viral infections closest to 2019-nCoV with four COVID-19 clinical presentations followed by functional enrichment of shared dysregulated genes. Potential chemical antagonists were also identified using protein-chemical interaction analysis. Based on phylogram analysis, the 2019-nCoV was found genetically closest to SARS-CoVs. In addition, we identified 562 upregulated and 738 downregulated genes (adj. P ≤ 0.05) with SARS-CoV infection. Among the dysregulated genes, SARS-CoV shared ≤19 upregulated and ≤22 downregulated genes with each of different COVID-19 complications. Notably, upregulation of BCL6 and PFKFB3 genes was common to SARS-CoV, pneumonia and severe acute respiratory syndrome, while they shared CRIP2, NSG1 and TNFRSF21 genes in downregulation. Besides, 14 genes were common to different SARS-CoV comorbidities that might influence COVID-19 disease. We also observed similarities in pathways that can lead to COVID-19 and SARS-CoV diseases. Finally, protein-chemical interactions suggest cyclosporine, resveratrol and quercetin as promising drug candidates against COVID-19 as well as other SARS-like viral infections. The pathogenetic analyses, along with identified biomarkers, signaling pathways and chemical antagonists, could prove useful for novel drug development in the fight against the current global 2019-nCoV pandemic
Language eng
DOI 10.1093/bib/bbaa173
Field of Research 0601 Biochemistry and Cell Biology
0802 Computation Theory and Mathematics
0899 Other Information and Computing Sciences
HERDC Research category C1 Refereed article in a scholarly journal
Persistent URL http://hdl.handle.net/10536/DRO/DU:30140750

Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 8 times in TR Web of Science
Scopus Citation Count Cited 10 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 8 Abstract Views, 1 File Downloads  -  Detailed Statistics
Created: Wed, 12 Aug 2020, 04:19:09 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.